A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]
Status: | Completed |
---|---|
Conditions: | HIV / AIDS |
Therapuetic Areas: | Immunology / Infectious Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 9/30/2018 |
Start Date: | June 2010 |
End Date: | July 2013 |
The purpose of this study is to see if a computer counseling tool helps Spanish-speaking
people living with HIV to have safer sex and to do well on their HIV medicines.
people living with HIV to have safer sex and to do well on their HIV medicines.
Latinos are the fastest-growing group with some of the largest health disparities including
HIV. Barriers including language are associated with lower antiretroviral therapy (ART)
adherence seen among Latinos. There are no evidence-based interventions (randomized trials
that significantly reduced viral load and HIV transmission risk to sexual partners -
'positive prevention') delivered in Spanish in routine clinical practice. Our computerized
counseling tool (CARE+) in a phase III trial of English-speaking adults increased ART
adherence and reduced viral load and condom use errors. We now propose a longitudinal
effectiveness (phase IV) study to evaluate the impact of computerized counseling in
audio-narrated Spanish in a busy urban HIV clinic. This 'CARE+ Spanish' proposal is
responsive to 06-OD(OBSSR)-101, for new technologies to improve adherence in clinical
practice. Aim 1: Adapt CARE+ Spanish for use during routine clinical visits by
Spanish-speaking HIV clinic attendees using an expert panel to shorten content and add
Spanish audio dialects; do usability testing (n≤8). Aim 2: Establish real-world utility of
'CARE+ Spanish'. Peer staff will recruit Spanish-speaking adults on ART who will be randomly
assigned to intervention (Group A n=250) or risk-assessment control (B, n=250) for
0,3-,6-,9-month sessions; at 12-month session groups will switch to opposite arm (delayed
intervention design). Linear and generalized linear mixed effects models will analyze impact
on 30-day ART adherence, clinic visit adherence, HIV-1 viral load and sexual risks, and to
assess whether any Group A changes are sustained at month 12, among an expected n=400
retained study participants (120 female, 280 male). Aim 3: Explore cultural acceptability of
tool among clients and clinic providers. Conduct qualitative exit interviews with patients
(n=75) to assess technology uptake factors, cultural/linguistic acceptability, and
suggestions for ongoing use among older vs. younger, and US-born vs. foreign-born Latino
groups. Conduct two focus groups with providers (n≤30) to assess perceived technology
barriers/facilitators. Analysis will identify factors affecting acceptability, utilization,
and impact. Technology tools like CARE+ present significant opportunities to bridge the
health promotion delivery gap, especially if linguistically adapted for often-neglected
groups such as Latinos (15% of the US population).
HIV. Barriers including language are associated with lower antiretroviral therapy (ART)
adherence seen among Latinos. There are no evidence-based interventions (randomized trials
that significantly reduced viral load and HIV transmission risk to sexual partners -
'positive prevention') delivered in Spanish in routine clinical practice. Our computerized
counseling tool (CARE+) in a phase III trial of English-speaking adults increased ART
adherence and reduced viral load and condom use errors. We now propose a longitudinal
effectiveness (phase IV) study to evaluate the impact of computerized counseling in
audio-narrated Spanish in a busy urban HIV clinic. This 'CARE+ Spanish' proposal is
responsive to 06-OD(OBSSR)-101, for new technologies to improve adherence in clinical
practice. Aim 1: Adapt CARE+ Spanish for use during routine clinical visits by
Spanish-speaking HIV clinic attendees using an expert panel to shorten content and add
Spanish audio dialects; do usability testing (n≤8). Aim 2: Establish real-world utility of
'CARE+ Spanish'. Peer staff will recruit Spanish-speaking adults on ART who will be randomly
assigned to intervention (Group A n=250) or risk-assessment control (B, n=250) for
0,3-,6-,9-month sessions; at 12-month session groups will switch to opposite arm (delayed
intervention design). Linear and generalized linear mixed effects models will analyze impact
on 30-day ART adherence, clinic visit adherence, HIV-1 viral load and sexual risks, and to
assess whether any Group A changes are sustained at month 12, among an expected n=400
retained study participants (120 female, 280 male). Aim 3: Explore cultural acceptability of
tool among clients and clinic providers. Conduct qualitative exit interviews with patients
(n=75) to assess technology uptake factors, cultural/linguistic acceptability, and
suggestions for ongoing use among older vs. younger, and US-born vs. foreign-born Latino
groups. Conduct two focus groups with providers (n≤30) to assess perceived technology
barriers/facilitators. Analysis will identify factors affecting acceptability, utilization,
and impact. Technology tools like CARE+ present significant opportunities to bridge the
health promotion delivery gap, especially if linguistically adapted for often-neglected
groups such as Latinos (15% of the US population).
Inclusion Criteria:
- Hispanic birth or ancestry
- Speaks Spanish (mono- or multi-lingual)
Exclusion Criteria:
- Lack of fluency in Spanish
- Thought disorder that precludes participation
- Inability to give informed consent due to altered mentation at time of enrollment
(e.g., visibly inebriated or high).
We found this trial at
1
site
Click here to add this to my saved trials